Mohammad Ali Nazarinia

939 total citations
69 papers, 681 citations indexed

About

Mohammad Ali Nazarinia is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Mohammad Ali Nazarinia has authored 69 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Rheumatology, 26 papers in Pathology and Forensic Medicine and 11 papers in Immunology. Recurrent topics in Mohammad Ali Nazarinia's work include Systemic Sclerosis and Related Diseases (23 papers), Systemic Lupus Erythematosus Research (13 papers) and Rheumatoid Arthritis Research and Therapies (12 papers). Mohammad Ali Nazarinia is often cited by papers focused on Systemic Sclerosis and Related Diseases (23 papers), Systemic Lupus Erythematosus Research (13 papers) and Rheumatoid Arthritis Research and Therapies (12 papers). Mohammad Ali Nazarinia collaborates with scholars based in Iran, Australia and United States. Mohammad Ali Nazarinia's co-authors include Saeedeh Shenavandeh, Zahra Habibagahi, Elham Aflaki, Parviz Khajehdehi, Leila Malekmakan, Gholamreza Dehghanzadeh, Fariborz Azad, Fariborz Ghaffarpasand, Masoume Rambod and Afshin Borhani‐Haghighi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Patient Education and Counseling.

In The Last Decade

Mohammad Ali Nazarinia

62 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Ali Nazarinia Iran 14 321 149 145 104 91 69 681
Przemysław Kotyla Poland 15 242 0.8× 156 1.0× 152 1.0× 23 0.2× 110 1.2× 60 635
Carolyn L. Bell United States 12 437 1.4× 93 0.6× 183 1.3× 26 0.3× 82 0.9× 25 731
Giovanni Conti Italy 18 75 0.2× 98 0.7× 121 0.8× 42 0.4× 211 2.3× 61 911
Cristina Sarasqueta Spain 16 261 0.8× 103 0.7× 172 1.2× 9 0.1× 90 1.0× 29 872
Peter Oelzner Germany 19 498 1.6× 228 1.5× 147 1.0× 6 0.1× 259 2.8× 92 1.1k
A. Abou‐Raya Egypt 12 226 0.7× 161 1.1× 186 1.3× 9 0.1× 89 1.0× 35 655
Burak Uz Türkiye 13 66 0.2× 49 0.3× 35 0.2× 13 0.1× 56 0.6× 44 604
Russell A. Settipane United States 20 192 0.6× 42 0.3× 144 1.0× 16 0.2× 47 0.5× 61 1.5k
Robert T. Keenan United States 20 467 1.5× 149 1.0× 114 0.8× 98 0.9× 352 3.9× 50 1.3k

Countries citing papers authored by Mohammad Ali Nazarinia

Since Specialization
Citations

This map shows the geographic impact of Mohammad Ali Nazarinia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Ali Nazarinia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Ali Nazarinia more than expected).

Fields of papers citing papers by Mohammad Ali Nazarinia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Ali Nazarinia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Ali Nazarinia. The network helps show where Mohammad Ali Nazarinia may publish in the future.

Co-authorship network of co-authors of Mohammad Ali Nazarinia

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Ali Nazarinia. A scholar is included among the top collaborators of Mohammad Ali Nazarinia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Ali Nazarinia. Mohammad Ali Nazarinia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Soltani, Leila, et al.. (2024). First study of the detection of Human Herpes Virus-8 and major blood-borne viruses in iranian patients with SLE: A cross-sectional study. New Microbes and New Infections. 60-61. 101445–101445.
3.
4.
Pasyar, Nilofar, et al.. (2023). A smartphone-based supportive counseling on health anxiety and acceptance of disability in Systemic Lupus Erythematosus patients: A randomized clinical trial. Patient Education and Counseling. 110. 107676–107676. 5 indexed citations
5.
6.
7.
Hashempour, Tayebeh, et al.. (2021). Comparison of the prevalence of HBV, HCV, HIV, CMV and EBV infections in patients with systemic lupus erythromatosus and healthy population. SHILAP Revista de lepidopterología. 79(2). 93–101. 1 indexed citations
8.
Hashempour, Tayebeh, et al.. (2021). First report of HHV-8 viral load and seroprevalence of major blood-borne viruses in Iranian patients with systemic sclerosis. Multiple Sclerosis and Related Disorders. 51. 102872–102872. 10 indexed citations
9.
Gharibdoost, Farhad, Mansour Salesi, Maryam Sahebari, et al.. (2021). Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study. Advances in Therapy. 38(2). 1290–1300. 4 indexed citations
10.
Ebrahimi, Bahareh, et al.. (2020). Calprotectin, an available prognostic biomarker in systemic sclerosis: a systematic review. Clinical Rheumatology. 40(5). 1709–1715. 7 indexed citations
11.
Nazarinia, Mohammad Ali, et al.. (2020). Psychometric Properties of Persian Version of the Rheumatoid Arthritis Quality of Life scale. The Neuroscience Journal of Shefaye Khatam. 8(2). 47–54.
12.
Rambod, Masoume, et al.. (2018). The impact of dietary habits on the pathogenesis of rheumatoid arthritis: a case-control study. Clinical Rheumatology. 37(10). 2643–2648. 29 indexed citations
13.
Nazarinia, Mohammad Ali, et al.. (2017). One decade distinct features, morbidity and mortality of scleroderma: a cross-sectional study.. PubMed. 34 Suppl 100(5). 74–78. 8 indexed citations
14.
Shenavandeh, Saeedeh, et al.. (2017). Nailfold digital capillaroscopic findings in patients with diffuse and limited cutaneous systemic sclerosis. Reumatologia/Rheumatology. 55(1). 23–31. 13 indexed citations
15.
Shenavandeh, Saeedeh, et al.. (2015). Determination of serum visfatin levels in patients with Behçet’s disease: A case–control study. The Egyptian Rheumatologist. 38(1). 41–45. 1 indexed citations
16.
Nazarinia, Mohammad Ali, et al.. (2014). Asymptomatic atlantoaxial subluxation in rheumatoid arthritis.. PubMed. 52(6). 462–6. 8 indexed citations
17.
18.
Nazarinia, Mohammad Ali, et al.. (2013). Efficacy of methotrexate in patients with polymyalgia rheumatica. SHILAP Revista de lepidopterología. 10 indexed citations
19.
Nazarinia, Mohammad Ali, et al.. (2013). Serum Homocystein Level in Patients With Scleroderma. Iranian Red Crescent Medical Journal. 15(1). 29–31. 5 indexed citations
20.
Bagheri, Fereshteh, et al.. (2013). The Prevalence of Psychiatric Symptoms in The Patients with Behcet's Disease in Shiraz, Southwest. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Przemysław Kotyla Breakdown of academic impact, for papers by Carolyn L. Bell Breakdown of academic impact, for papers by Giovanni Conti Breakdown of academic impact, for papers by Cristina Sarasqueta Breakdown of academic impact, for papers by Peter Oelzner Breakdown of academic impact, for papers by A. Abou‐Raya Breakdown of academic impact, for papers by Burak Uz Breakdown of academic impact, for papers by Russell A. Settipane Breakdown of academic impact, for papers by Robert T. Keenan
Rankless by CCL
2026